Identity
HGNC
LOCATION
16q21
LOCUSID
ALIAS
A-152E5.1,ABCD-1,DC/B-CK,MDC,SCYA22,STCP-1
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 6367
MIM: 602957
HGNC: 10621
Ensembl: ENSG00000102962
Variants:
dbSNP: 6367
ClinVar: 6367
TCGA: ENSG00000102962
COSMIC: CCL22
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000102962 | ENST00000219235 | O00626 |
Expression (GTEx)
Pathways
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38387281 | 2024 | Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis. | 0 |
| 38924414 | 2024 | Macrophage-derived chemokine CCL22 establishes local LN-mediated adaptive thermogenesis and energy expenditure. | 0 |
| 38387281 | 2024 | Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis. | 0 |
| 38924414 | 2024 | Macrophage-derived chemokine CCL22 establishes local LN-mediated adaptive thermogenesis and energy expenditure. | 0 |
| 36792811 | 2023 | Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia. | 1 |
| 37124725 | 2023 | CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction. | 1 |
| 37685890 | 2023 | Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19. | 2 |
| 36792811 | 2023 | Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia. | 1 |
| 37124725 | 2023 | CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction. | 1 |
| 37685890 | 2023 | Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19. | 2 |
| 35962191 | 2022 | Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC). | 12 |
| 36224014 | 2022 | Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL). | 2 |
| 35962191 | 2022 | Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC). | 12 |
| 36224014 | 2022 | Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL). | 2 |
| 32480426 | 2021 | Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22. | 6 |
Citation
Dessen P
CCL22 (C-C motif chemokine ligand 22)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/46211/ccl22
